To examine whether the CD47:SIRPα immune checkpoint is a negative regulator of ADP in NLCs from CLL patients we initially quantitated leukemic cell surface expression of CD47 by flow cytometry (Figure 2A) and NLC SIRPα expression by western blot (Figure 2B). The gene discussed is CD47; the disease is B-cell chronic lymphocytic leukemia.